MeiraGTx Holdings (MGTX) Interest & Investment Income (2017 - 2026)
MeiraGTx Holdings' (MGTX) quarterly Interest & Investment Income came in at $278000.0 in Q4 2025, down 73.06% YoY from $1.0 million in Q4 2024, and up 72.67% on a QoQ basis from $161000.0 in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Interest & Investment Income (2017 - 2026) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Interest & Investment Income data on file, last reported at $278000.0 in Q4 2025.
- Quarterly Interest & Investment Income fell 73.06% year-over-year to $278000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.8 million (down 56.14% YoY) and the FY2025 annual result came in at $1.8 million, down 56.14% from the prior year.
- Interest & Investment Income climbed to $278000.0 in Q4 2025, from $161000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.2 million in Q3 2024 to a low of $16000.0 in Q1 2022.
- A 5-year average of $461250.0 and a median of $420000.0 in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2021 — Interest & Investment Income plunged 88.72% — and 2023, when it surged 3306.25%.
- Tracing MGTX's Interest & Investment Income over 5 years: stood at $24000.0 in 2021, then soared by 1700.0% to $432000.0 in 2022, then gained by 27.08% to $549000.0 in 2023, then soared by 87.98% to $1.0 million in 2024, then sank by 73.06% to $278000.0 in 2025.
- The last three Interest & Investment Income figures came in at $278000.0 (Q4 2025), $161000.0 (Q3 2025), and $408000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | 706,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 706,000.00 |
| Dec 31, 2025 | 278,000.00 |
| Sep 30, 2025 | 161,000.00 |
| Jun 30, 2025 | 408,000.00 |
| Mar 31, 2025 | 971,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 827,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 549,000.00 |
| Sep 30, 2023 | 523,000.00 |
| Jun 30, 2023 | 655,000.00 |
| Mar 31, 2023 | 545,000.00 |
| Dec 31, 2022 | 432,000.00 |
| Sep 30, 2022 | 288,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 24,000.00 |
| Sep 30, 2021 | 33,000.00 |
| Jun 30, 2021 | 67,000.00 |